+499.5%
MRNA vs NTAP
+61.4%
+438.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -2.2% |
| 7D | +5.5% | -0.8% | +6.2% | +5.3% |
| 30D | +158.7% | -0.5% | +159.3% | +149.1% |
| 3M | +182.1% | +4.1% | +178.1% | +169.9% |
| 6M | +151.8% | +88.0% | +63.9% | +100.4% |
| YTD | +393.6% | +75.6% | +318.0% | +297.4% |
| 1Y | +499.5% | +58.9% | +440.6% | +407.3% |
| All | +499.5% | +61.4% | +438.1% | +407.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling